Novo Nordisk A/S
NVO institutional ownership changes in Q2 2026: 120 institutions opened or added positions, 119 trimmed or exited. NVO (Novo Nordisk A/S) is held by 234 institutional investors as of Q2 2026. Top institutional shareholders: Dodge & Cox ($977.8M), Loomis, Sayles & Co., L.P. ($891.4M), Franklin Templeton Inc. ($625.2M). Institutions were buying, on balance.
Who's Trading
Latest move
Source dates: Price Nov 6, 2026 · Insiders none · Activists none · Congress Sep 25, 2026
Top Holders
| Action | ||||||
|---|---|---|---|---|---|---|
Increased | 20.4M(+5.5%) | $977.8M | 0.5% | +9.35% | 47 | |
Increased | 18.6M(+9.3%) | $891.4M | 1.1% | -4.03% | 55 | |
Decreased | 13M(-18.9%) | $625.2M | 0.1% | -21.70% | 0 | |
Increased | 11.7M(+5.8%) | $561.1M | 0.1% | -32.92% | 33 | |
Increased | 11.7M(+7.3%) | $559M | 0.0% | -64.86% | 34 | |
Increased | 11.2M(+3.8%) | $535.8M | 0.0% | -41.26% | 33 | |
Decreased | 9.7M(-17.6%) | $467.6M | 0.1% | -21.86% | 0 | |
Increased | 9.2M(+79.3%) | $440.1M | 0.0% | -23.14% | 48 | |
Decreased | 8.3M(-7.7%) | $399.1M | 0.1% | +134.86% | 0 | |
Increased | 8.3M(+5.7%) | $396.5M | 0.2% | +9.30% | 39 | |
Unchanged | 6.1M | $294.5M | 0.2% | +109.51% | 0 | |
Increased | 5.9M(+0.6%) | $284.6M | 0.0% | +75.17% | 31 | |
Increased | 5.4M(+19.2%) | $258.8M | 0.0% | -36.23% | 36 | |
Decreased | 5.2M(-0.1%) | $249.6M | 0.0% | +7.57% | 0 | |
New | 4.9M | $235.3M | 0.8% | -14.84% | 60 | |
Decreased | 4.8M(-56.6%) | $230.9M | 0.0% | +2.94% | 0 | |
Increased | 4.7M(+27.9%) | $223.3M | 0.0% | -12.35% | 38 | |
Increased | 4M(+1.8%) | $193.3M | 0.0% | -28.33% | 31 | |
Decreased | 4M(-12.7%) | $191M | 0.0% | -32.46% | 0 | |
Increased | 3.9M(+30.8%) | $185.1M | 0.0% | -57.52% | 39 |
Showing 1-20 of 249
| Member | Trade | Traded |
|---|---|---|
| Kevin Hern | Sale $1,001 - $15,000 | |
| Kevin Hern | Sale $1,001 - $15,000 | |
| Scott Scott Franklin | Buy $1,001 - $15,000 | |
| Alan Armstrong | Buy $15,001 - $50,000 | |
| Lisa McClain | Sale $1,001 - $15,000 | |
| Lisa McClain | Sale $1,001 - $15,000 | |
| Marjorie Taylor Greene | Sale $1,001 - $15,000 | |
| Lisa McClain | Sale $1,001 - $15,000 | |
| Marjorie Taylor Greene | Sale $1,001 - $15,000 | |
| Marjorie Taylor Greene | Sale $15,001 - $50,000 |
NVONovo Nordisk A/SContinue exploring
Other Healthcare stocks held by institutions
UNHUnitedHealth Group Incorporated
LLYEli Lilly and Company
TMOThermo Fisher Scientific Inc
JNJJohnson & Johnson
DHRDanaher Corporation
ISRGIntuitive Surgical, Inc.
MRKMerck & Company, Inc.
ABBVAbbVie Inc.
BSXBoston Scientific Corporation
ABTAbbott LaboratoriesQuestions investors ask about NVO
Who owns NVO?
234 institutional investors held NVO on June 30, 2026, led by Dodge & Cox ($977.8M), Loomis, Sayles & Co., L.P. ($891.4M) and Franklin Templeton Inc. ($625.2M).
How many hedge funds hold NVO?
234 institutional investors reported NVO in their 13F filings for the quarter ended June 30, 2026, $12.4B in all. 18 of them are rated Elite.
Are institutions buying or selling NVO?
Buying, on balance. In Q2 2026, 120 institutions opened or added to positions in NVO and 119 institutions trimmed or exited.
Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer